Collateral lessons from recent acute ischemic stroke trials

Neurological Research

Volumn 36, Issue 5, 2014, Pages 397-402

  Liebeskind, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Collateral; Ischemia; Neuroprotection; Reperfusion; Stroke

Indexed keywords

ANGIOGRAPHY; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COLLATERAL CIRCULATION; HEALTH CARE ORGANIZATION; HEMODYNAMICS; HUMAN; INFORMATION PROCESSING; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; OUTCOME ASSESSMENT; PERFUSION; POSTERIOR COMMUNICATING ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; TREATMENT PLANNING; BRAIN; BRAIN ANGIOGRAPHY; BRAIN CIRCULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STROKE; VASCULARIZATION;

BRAIN; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84898713959     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000348     Document Type: Article

References (25)

1. Shuaib A, Butcher K, Mohammad AA, Saqqur M, Liebeskind DS. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol. 2011;10:909-21.
2. Shuaib A, Bornstein NM, Diener HC, Dillon W, Fisher M, Hammer MD, et al. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in acute ischemic stroke trial. Stroke. 2011;42:1680-90.
3. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893-903.
4. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904-13.
5. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914-23.
6. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-40.
7. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-9.
8. Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2008;79:625-9.
9. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke. 2011;42:693-9.
10. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke. 2011;42:2235-9.
11. Liebeskind DS. Collateral perfusion: time for novel paradigms in cerebral ischemia. Int J Stroke. 2012;7:309-10.
12. Liebeskind DS. Collateral circulation. Stroke. 2003;34:2279-84.
13. Liebeskind DS. Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics. Curr Opin Neurol. 2010;23:36-45.
14. Liebeskind DS. Venous hemodynamics may enhance collateral perfusion and the fibrinolytic milieu in paradoxical embolism. Stroke. 2009;40:e30-1.
15. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109-37.
16. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-4.
17. Azizyan A, Sanossian N, Mogensen MA, Liebeskind DS. Fluid-attenuated inversion recovery vascular hyperintensities: an important imaging marker for cerebrovascular disease. AJNR Am J Neuroradiol. 2011;32:1771-5.
18. Sanossian N, Saver JL, Alger JR, Kim D, Duckwiler GR, Jahan R, et al. Angiography reveals that fluid-attenuated inversion recovery vascular hyperintensities are due to slow flow, not thrombus. AJNR Am J Neuroradiol. 2009;30:564-8.
19. Schellinger PD, Kohrmann M, Liu S, Dillon WP, Nogueira RG, Shuaib A, et al. Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo technology in ischemic stroke trial. Stroke. 2013;44:1606-8.
20. Leker RR, Molina C, Cockroft K, Liebeskind DS, Concha M, Shuaib A, et al. Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients. Cerebrovasc Dis. 2012;34:263-71.
21. Liebeskind DS. Trials of endovascular therapies or collaterals? Int J Stroke. 2013;8:258-9.
22. Liebeskind DS, Tomsick TA, Yeatts S, Yeatts SD, Carrozzella J, Demchuk AM, et al. Collaterals in the interventional management of stroke (IMS) III trial. Stroke. 2013;44:AWP5.
23. Yoo AJ, Simonsen CZ, Prabhakaran S, Chaudhry ZA, Issa MA, Fugate JE, et al. Refining angiographic biomarkers of revascularization: improving outcome prediction after intraarterial therapy. Stroke. 2013;44:2509-12.
24. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650-63.
25. Liebeskind DS. Collateral therapeutics for cerebral ischemia. Expert Rev Neurother. 2004;4:255-65.